Works matching IS 13866346 AND DT 2018 AND VI 48 AND IP 10


Results: 10
    1
    2
    3
    4
    5
    6
    7

    Efficacy of ledipasvir/sofosbuvir with or without ribavirin for 12 weeks in genotype 1b HCV patients previously treated with a nonstructural protein 5A inhibitor‐containing regimen.

    Published in:
    Hepatology Research, 2018, v. 48, n. 10, p. 802, doi. 10.1111/hepr.13074
    By:
    • Ikeda, Hiroki;
    • Watanabe, Tsunamasa;
    • Shimizu, Hirohito;
    • Hiraishi, Tetsuya;
    • Kaneko, Rena;
    • Baba, Toshiyuki;
    • Takahashi, Hideaki;
    • Matsunaga, Kotaro;
    • Matsumoto, Nobuyuki;
    • Yasuda, Hiroshi;
    • Okuse, Chiaki;
    • Iwabuchi, Shogo;
    • Suzuki, Michihiro;
    • Itoh, Fumio
    Publication type:
    Article
    8

    Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real‐world practice.

    Published in:
    Hepatology Research, 2018, v. 48, n. 10, p. 814, doi. 10.1111/hepr.13180
    By:
    • Uchikawa, Shinsuke;
    • Kawaoka, Tomokazu;
    • Aikata, Hiroshi;
    • Kodama, Kenichiro;
    • Nishida, Yuno;
    • Inagaki, Yuki;
    • Hatooka, Masahiro;
    • Morio, Kei;
    • Nakahara, Takashi;
    • Murakami, Eisuke;
    • Hiramatsu, Akira;
    • Tsuge, Masataka;
    • Imamura, Michio;
    • Kawakami, Yoshiiku;
    • Chayama, Kazuaki
    Publication type:
    Article
    9
    10

    Issue Information.

    Published in:
    Hepatology Research, 2018, v. 48, n. 10, p. 769, doi. 10.1111/hepr.13032
    Publication type:
    Article